BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3789334)

  • 1. Characterization of the in vivo and in vitro effects of indomethacin on human natural killer cell activity.
    Pedersen BK; Oxholm P; Klarlund K
    Allergy; 1986 Sep; 41(7):532-6. PubMed ID: 3789334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inert particles inhibit natural killer cell function in vitro.
    Sibbitt WL; Imir T; Bankhurst AD
    Cell Immunol; 1986 Jan; 97(1):146-54. PubMed ID: 2427217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chloroquine, mefloquine and quinine on natural killer cell activity in vitro. An analysis of the inhibitory mechanism.
    Pedersen BK; Bygbjerg IC; Theander TG; Andersen BJ
    Allergy; 1986 Sep; 41(7):537-42. PubMed ID: 2431633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indomethacin in vitro and in vivo abolishes post-exercise suppression of natural killer cell activity in peripheral blood.
    Pedersen BK; Tvede N; Klarlund K; Christensen LD; Hansen FR; Galbo H; Kharazmi A; Halkjaer-Kristensen J
    Int J Sports Med; 1990 Apr; 11(2):127-31. PubMed ID: 2338373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence in vitro on NK and K cell activities by cimetidine and indomethacin with and without simultaneous exposure to interferon.
    Flodgren P; Sjögren HO
    Cancer Immunol Immunother; 1985; 19(1):28-34. PubMed ID: 3844972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of rat colon intraepithelial lymphocyte (IEL) natural killer (NK) activity with indomethacin.
    Ross DS; Roy TR
    Adv Exp Med Biol; 1987; 216A():527-31. PubMed ID: 3687538
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
    Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
    Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocyte- and natural killer cell-mediated spontaneous cytotoxicity against human noncultured solid tumor cells.
    Itoh K; Platsoucas CD; Balch CM
    Cell Immunol; 1987 Sep; 108(2):495-500. PubMed ID: 3113744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of cytotoxic activity of natural killer cells by interleukin 2, and antagonism between interleukin 2 and adenosine cyclic monophosphate.
    Chun M; Krim M; Granelli-Piperno A; Hirst JA; Hoffmann MK
    Scand J Immunol; 1985 Oct; 22(4):375-81. PubMed ID: 2416040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis.
    Lala PK; Parhar RS; Singh P
    Cell Immunol; 1986 Apr; 99(1):108-18. PubMed ID: 2944621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kupffer cells modulate natural killer cell activity in vitro by producing prostaglandins.
    Okumura Y; Ishibashi H; Shirahama M; Kurokawa S; Kudo J; Okubo H; Niho Y
    Cell Immunol; 1987 Jun; 107(1):89-98. PubMed ID: 3581176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired indomethacin-boosting of the defective natural killer cell activity in patients with primary Sjögren's syndrome.
    Pedersen BK; Oxholm P; Manthorpe R; Andersen V
    Scand J Rheumatol Suppl; 1986; 61():135-8. PubMed ID: 3473621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the platelet-activating factor antagonist BN 52021 on human natural killer cell cytotoxicity.
    Mandi Y; Farkas G; Koltai M; Beladi I; Braquet P
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):222-4. PubMed ID: 2540096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers.
    Sibbitt WL; Mathews PM; Bankhurst AD
    J Clin Invest; 1983 May; 71(5):1230-9. PubMed ID: 6853711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of natural killer cell activity of human lymphocytes by eicosapentaenoic acid.
    Yamashita N; Yokoyama A; Hamazaki T; Yano S
    Biochem Biophys Res Commun; 1986 Aug; 138(3):1058-67. PubMed ID: 3019330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen and antiestrogen modulation of the levels of mouse natural killer activity and large granular lymphocytes.
    Screpanti I; Santoni A; Gulino A; Herberman RB; Frati L
    Cell Immunol; 1987 May; 106(2):191-202. PubMed ID: 2882860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulphasalazine and derivatives, natural killer activity and ulcerative colitis.
    Gibson PR; Jewell DP
    Clin Sci (Lond); 1985 Aug; 69(2):177-84. PubMed ID: 2866061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of natural killing by tumor promoters: the regulatory influence of adherent cells varies with the type of target cell.
    Kabelitz D
    Immunobiology; 1985 May; 169(4):436-46. PubMed ID: 2408998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGE2-mediated immunosuppression by first trimester human decidual cells blocks activation of maternal leukocytes in the decidua with potential anti-trophoblast activity.
    Parhar RS; Yagel S; Lala PK
    Cell Immunol; 1989 Apr; 120(1):61-74. PubMed ID: 2784722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.